Chad Winters - Mar 11, 2024 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP, Chief Accounting Officer
Signature
/s/ Luis Cantarero
Stock symbol
WST
Transactions as of
Mar 11, 2024
Transactions value $
-$175,512
Form type
4
Date filed
3/12/2024, 11:46 AM
Previous filing
Feb 22, 2024
Next filing
Feb 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $117K +675 +46.59% $173.22 2.12K Mar 11, 2024 Direct F1
transaction WST Common Stock Sale -$292K -815 -38.38% $358.82 1.31K Mar 11, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Options Exercise $0 -675 -42.97% $0.00 896 Mar 11, 2024 Stock Options (Right to Buy) 675 $173.22 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2021 PSUs (PP20) award vesting net of taxes withheld.